- JP-listed companies
- TAIKO PHARMACEUTICAL CO., LTD.
- Income statement
TAIKO PHARMACEUTICAL CO., LTD.【JP:4574】Income statement
Market cap
¥14.6B
P/E ratio
25x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 6,684 | 7,444 | 9,947 | 8,979 | 8,327 | 8,295 | 9,459 | 10,419 | 14,966 | 17,583 | 11,299 | 5,040 | 6,120 | 6,292 |
| Cost of revenue | - | - | - | 2,355 | 2,556 | 2,714 | 2,886 | 3,216 | 4,358 | 5,263 | 7,973 | 3,961 | 3,543 | 2,626 |
| Gross profit | - | - | - | 6,624 | 5,771 | 5,581 | 6,573 | 7,203 | 10,608 | 12,320 | 3,325 | 1,078 | 2,577 | 3,666 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating expenses | - | - | - | 4,324 | 4,391 | 4,025 | 4,695 | 5,132 | 6,754 | 6,770 | 7,694 | 4,157 | 3,583 | 3,036 |
| Operating income | - | - | - | 2,559 | 1,348 | 1,545 | 1,857 | 2,030 | 3,825 | 5,651 | -4,947 | -3,079 | -1,005 | 629 |
| Income before tax | 559 | 1,212 | 2,684 | 2,776 | 1,307 | 1,408 | 1,568 | 1,885 | 3,633 | 5,454 | -6,131 | -3,352 | -1,248 | 688 |
| Provision for income taxes | - | - | - | 988 | 351 | 442 | 458 | 570 | 1,051 | 1,523 | 706 | 25 | 47 | -332 |
| Net income | 373 | 899 | 1,536 | 1,771 | 840 | 1,049 | 1,095 | 1,415 | 2,453 | 3,852 | -9,594 | -4,895 | -3,611 | 898 |
| Earnings per share | 37.23 | 81.31 | 135.94 | 138.93 | 65.23 | 76.45 | 77.38 | 98.99 | 57.57 | 89.18 | -220.52 | -112.26 | -76.25 | 17.9 |
| Diluted EPS | 36.51 | 80.09 | 131.56 | 134.47 | 63.83 | 75.81 | 77.06 | 98.88 | 57.34 | 88.82 | - | - | - | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Dividend per share | 15 | 15 | 25 | 25 | 15 | 20 | 25 | 35 | 50 | 25 | - | - | - | - |